3rd Party Biotechnology Industry News

As Neuphoria Therapeutics considers its options in the wake of [...]

CeleCor presented the results of its pivotal CeleBrate phase 3 [...]

Voyager Therapeutics is shoving off on a new journey to [...]

Cogent Biosciences has cleared another phase 3 hurdle for its [...]

After a chaotic and fierce bidding clash that only burst [...]

Amid Novo Nordisk and Pfizer’s whiplash bidding war for obesity [...]

Sana Biotechnology, CAMP4 Therapeutics and Crinetics Pharmaceuticals have all used [...]

The patient who was hospitalized after receiving Intellia Therapeutics’ CRISPR [...]

Twelve years after establishing TechBio company Recursion, co-founder and CEO [...]

Biotech firm prepares for pivotal trials as it positions Teverelix [...]